ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
18 avr. 2022 07h30 HE
|
ContraFect Corporation
YONKERS, N.Y., April 18, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
ContraFect Announces BARDA Contract Award for Up to $86.8 Million and Provides Business Outlook
11 mars 2021 16h05 HE
|
ContraFect Corporation
BARDA to provide funding for the ongoing Phase 3 DISRUPT study of exebacase for the treatment of patients with Staph aureus bloodstream infections Results from the Phase 3 DISRUPT study interim...
Kraig Biocraft Laboratories Announces Spider Silk Patent Granted in Canada
02 mars 2021 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., March 02, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the biotechnology company focused on the development and...
Kraig Biocraft Laboratories receives its first-ever Spider Silk shipment from its Vietnamese production facility
23 févr. 2021 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and...
Kraig Biocraft Laboratories files for International Patents in Key Spider Silk Knock-in Knock-out Technology
16 févr. 2021 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and...
ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors
11 févr. 2021 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs)...
Kraig Biocraft Laboratories and MtheMovement by Kings Group sign Exclusive Purchase and Sales Agreement for up to potentially $40 million
26 janv. 2021 07h05 HE
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and...
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.
04 janv. 2021 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
05 oct. 2020 10h13 HE
|
ImmunoPhotonics, Inc.
ST. LOUIS, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers for the...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
05 oct. 2020 04h13 HE
|
ImmunoPhotonics, Inc.
BERN, Switzerland, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers...